The Systemic Assessment to the Clinical Value of Serum Tumor Markers for the Diagnosis of Pancreatic Cancer

Wei-li YAN,Xing-dang LIU,Ji-cong GUI,Xu SUN

DOI: https://doi.org/10.11748/bjmy.issn.1006-1703.2014.02.001

2014-01-01

Abstract:Objective Pancreatic cancer has the worst prognosis of any gastrointestinal cancer,with the mortality approaching the incidence. Early detection is crucial for improving patient prognosis. We therefore performed a meta-analysis to evaluate and compare the sensitivity and specificity of CA19-9 and CA242 in pancreatic cancer. Methods We searched PubMed,EMBASE and the Cochrane Library for studies that evaluated the diagnostic validity of CA19-9 and CA242 between January 1966 and March 2011. Meta-analysis methods were used to pool sensitivity and specificity and to construct a summary receiver-operating characteristic( SROC)curve. Results A total of 11 studies that included 2316 patients who full filled all of the inclusion criteria were considered for analysis. The pooled sensitivities for CA242 and CA19-9 were 0. 719( 95% CI: 0. 690-0. 746) and 0. 803(95% CI: 0. 777- 0. 826),respectively. The pooled specificities of CA242 and CA19-9were 0. 868(95% CI: 0. 849- 0. 885) and 0. 802(95% CI,0. 780- 0. 823),respectively. The diagnostic odds ratio( DOR) estimate was significantly higher for CA242( 16. 261) than for CA19-9( 15. 637).Conclusion Our meta-analysis showed that CA242 and CA19-9 could play different roles in the diagnosis of pancreatic cancer. Although the sensitivity of CA242 is lower than that of CA19-9,its specificity is greater.